Edelweiss Technology Fund - Regular (G)

Change in the name of the Scheme:

Edelweiss Balanced Advantage Fund – Regular Plan – Monthly IDCW Option & Direct Plan – Monthly IDCW Option: Rs. 0.18 each

Edelweiss Aggressive Hybrid Fund – Regular Plan – IDCW Option & Direct Plan – IDCW Option: Rs. 0.20 each.

Edelweiss Equity Savings Fund – Regular Plan – Monthly IDCW Option & Direct Plan – Monthly IDCW Option: Rs. 0.08 each.

Aditya Birla Sun Life Balanced Advantage Fund:

Regular Plan – IDCW Option: 0.156

Direct Plan – IDCW Option: 0.177

Aditya Birla Sun Life Arbitrage Fund:

Regular Plan – IDCW Option: 0.065

Direct Plan – IDCW Option: 0.067

Aditya Birla Sun Life Equity Hybrid '95 Fund:

Regular Plan – IDCW Option: 3.176

Direct Plan – IDCW Option: 5.423

Aditya Birla Sun Life Dividend Yield Fund:

Regular Plan – IDCW Option: 0.407

Direct Plan – IDCW Option: 0.737

Aditya Birla Sun Life Equity Savings Fund:

Regular Plan – IDCW Option: 0.235

Direct Plan – IDCW Option: 0.276

Sundaram Diversified Equity Fund - Regular Plan - IDCW Option: 0.126

Sundaram Diversified Equity Fund - Direct Plan - IDCW Option: 0.153

Change in Fund Manager:

Details of Mr. Rishi Sharma

Age: 47

Designation: Vice President Equities

Qualification : B Com - MS University – Vadodara, PGDBA in Finance

Sundaram Aggressive Hybrid Fund - Regular Plan-Monthly-IDCW Option: 0.250

Sundaram Aggressive Hybrid Fund - Direct Plan-Monthly-IDCW Option: 0.350

Sundaram Balanced Advantage Fund - Regular Plan-Monthly-IDCW Option: 0.115

Sundaram Balanced Advantage Fund - Direct Plan-Monthly-IDCW Option: 0.140

Change in Fund Manager:

Change in the name of the Scheme:

Change in Fund Manager:

Change in the name of the Scheme:

Invesco India Balanced Advantage Fund – Regular IDCW Option & Direct IDCW Option: 0.25

The Indian mutual fund industry continued its upward trajectory in May 2025, reaching a new high of Rs 72.19 lakh crore in net assets under management (AUM), according to data from the Association of Mutual Funds of India (AMFI). This marks a 3% rise compared to Rs 69.99 lakh crore at the end of April.

Open-ended schemes saw their AUM climb to Rs 71.93 lakh crore in May 2025, up from Rs 69.73 lakh crore in April 2025. Equity schemes within this category continued to attract investors, with net inflows adding up to Rs 19,013.12 crore.

Within equity, Flexi Cap Fund drew the most significant inflows in May, attracting Rs 3,841.32 crore. Small Cap Funds followed suit with Rs 3,214.21 crore, while equity linked saving schemes (ELSS) saw net outflows of Rs 678.11 crore.

Debt funds witnessed net outflows in May, totaling Rs 15,908.48 crore. This category had recorded net inflows of Rs 2,19,136.27 crore in April. Liquid funds recorded outflows of Rs 40,205.36 crore. Other debt segments like overnight fund, floater fund and credit risk fund also saw significant outflows.

Hybrid schemes, offering a mix of equity and debt exposure, bucked the trend with net inflows of Rs 20,765.05 crore in May. This was largely driven by arbitrage funds, which attracted Rs 15,701.97 crore.

The systematic investment plan (SIP) contributions reportedly hit an all-time high of Rs 26,688 crore in May 2025, making it the highest monthly SIP inflow on record. The number of contributing SIP accounts also rose to an all-time high of 8.56 crore.

Diviniti SIF enters a nascent but growing segment within the Indian mutual fund landscape. Specialized Investment Funds (SIFs) are characterized by their ability to offer more customized investment solutions compared to conventional mutual fund schemes. However, as with any investment vehicle, SIFs inherently carry risks, including potential loss of capital, liquidity risk, and market volatility.

The launch by ITI Asset Management follows similar strategic moves by other prominent players in the asset management sector. Last week, Mirae Asset Investment Managers (India) introduced Platinum SIF under the Mirae Asset Mutual Fund umbrella, also with the objective of offering specialized investment funds. Mirae Asset's plans include rolling out differentiated investment strategies across equity, hybrid, and fixed income within the existing mutual fund framework.

Prior to these developments, Edelweiss Asset Management had also established its presence in the SIF segment with the launch of altiva SIF. Edelweiss AMC has positioned SIFs as an intermediary solution, bridging the gap between traditional mutual funds and Portfolio Management Services (PMS), specifically targeting investors who seek greater innovation and flexibility in their investment portfolios.

The entry of multiple asset managers into the SIF space suggests a growing recognition of the demand for more bespoke investment products that can cater to specific investor needs beyond the scope of traditional mutual fund offerings.

The primary objective of the scheme is to provide long-term capital appreciation by investing primarily in equity and equity-related instruments of companies operating in the pharmaceutical and healthcare sectors. At least 80% of the fund’s assets will be allocated to businesses in these areas, including allied service providers.

The fund adopts an actively managed approach with a bottom-up stock selection strategy. It does not have a specific market capitalization preference, allowing for investments across large-cap, mid-cap, and small-cap companies. The fund will be managed by Sanjay Chawla. It carries an exit load of 1% if redeemed within 365 days. The minimum investment during the NFO is set at Rs 1,000.

India’s healthcare market, valued at approximately US$ 110 billion in FY16, is projected to grow to US$ 638 billion by FY25, with an estimated annual growth rate of 22%. This growth is supported by rising demand, technological advancements, and expanding infrastructure.

The fund aims to provide diversified exposure across the entire healthcare value chain. This includes pharmaceuticals and biotechnology, API manufacturers, and contract research and manufacturing organizations (CROs/CDMOs). It also covers hospitals, diagnostics, and medical devices, along with pharmacy retail. Additionally, the fund taps into the growing wellness segment, investing in fitness centers, nutritional supplements, and assisted living services.

Positioned as a long-term investment option, the scheme is aimed at investors seeking to benefit from the structural growth and increasing relevance of healthcare in India’s economic development. It is suitable for those with an investment horizon of three years or more, looking to participate in a sector that plays a critical role in improving societal well-being and supporting sustainable development.

The BSE 1000 Total Return Index represents the top 1,000 listed companies in India, covering approximately 94% of the country’s listed market capitalization. The index spans across large-, mid-, small-, and micro-cap stocks, and reflects the performance of 22 sectors, ranging from traditional industries to technology-driven enterprises. With a cap of ~33% on the top 10 stocks, the index structure aims to minimize concentration risk and deliver diversified exposure.

The fund's investment objective is to provide returns that closely correspond to the total returns of the BSE 1000 index, subject to tracking error. Investors can participate with a minimum lump sum of Rs 500, while exit load is 1% if redeemed within 15 days from allotment and nil thereafter.

Commenting on the launch, Pratik Oswal, chief of– passive business, Motilal Oswal Asset Management Company: "We are proud to launch India’s first index fund tracking the BSE 1000 Total Return Index, giving investors access to India’s largest and most inclusive equity index. This fund aims to captures the performance of 1,000 companies spanning large, mid, small, and micro-cap companies across 22 sectors. It provides a diversified exposure to India’s corporate sector and is a natural evolution for investors seeking a passive investment option. As pioneers in passive investing, our goal is to offer simple, low-cost, and scalable investment options, and this launch aligns with that objective."

The launch comes at a time when India’s macroeconomic outlook remains strong. Citing IMF projections, MOAMC expects India’s GDP to grow at 6.2% in 2025 and 6.3% in 2026, supported by a mix of domestic demand, policy reforms, and structural shifts across key industries.

For investors seeking broad-based, passive exposure to India’s equity story through a diversified and low-cost strategy, the Motilal Oswal BSE 1000 Index Fund offers a new point of entry aligned with India’s long-term economic vision.

Change in the name of the Scheme:

Change in name of Benchmark of Baroda BNP Paribas Multi Asset Active Fund of Funds

Change in Fund Manager: